Anti-TIF1γ antibodies can be detected in up to 35% of adult DM patients who are frequently diagnosed with lung, uterine, colon, breast, ovarian, and lymphoma cancers within three years [2,10,45]. This evidence concerns the gene TRIM33 and diabetes mellitus.